Lamotrigine
Treatment for Idiopathic epilepsy
Typical Dosage: 100-500 mg daily
Effectiveness
75%
Safety Score
65%
Clinical Trials
350
Participants
55K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
65
DangerousModerateSafe
Treatment Details
Dosage Range
100-500 mg daily
Time to Effect
Weeks to months
Treatment Duration
Lifetime
Evidence Quality
HIGHNumber Needed to Treat (NNT)
9(Treat 9 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
12(Treat 12 patients to see 1 additional serious adverse event)
Confidence Score
85%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$900
Monitoring:$400
Side Effect Mgmt:$200
Total Annual:$1,500
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTICER
$15,000/QALY
QALYs Gained
5
Outcome-Based Costs
Cost per Responder
$3,333
Cost per Remission
$4,286
Lamotrigine Outcomes
for Idiopathic epilepsy
Efficacy Outcomes
Overall Effectiveness
+75%
Response Rate
+45%
Remission Rate
+35%
Common Side Effects
Dizziness
+15%
Ataxia
+8%
Rash (including serious SJS/TEN)
+7%
Nausea
+6%
Headache
+6%
Sources:
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov